Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- 最新申報
- 2026/8/13
2022 年第 3 季持倉
持倉截至 2022/9/30，2022/11/14 申報。只含多頭部位，變化是跟 2022 年第 2 季比股數。
- 持股檔數
- 47
- 較 2022 年第 2 季 +7
- 總值
- $2.17 億
- 較 2022 年第 2 季 +$3,431 萬 (+18.8%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| ESTAEstablishment Labs Holdings Inc. | COM | 326,668 | $1,784 萬 | 8.2% | −33,288−9.2% | 減碼 | 歷史 |
| KDNYChinook Therapeutics, Inc. | COM | 813,998 | $1,600 萬 | 7.4% | −123,570−13.2% | 減碼 | 歷史 |
| GBTGlobal Blood Therapeutics, Inc. | COM | 190,000 | $1,294 萬 | 6.0% | +190,000 | 新進 | 歷史 |
| SNYSanofi | SPONSORED ADR | 300,000 | $1,141 萬 | 5.3% | +300,000 | 新進 | 歷史 |
| Retrophin Inc761299AB2 | NOTE 2.500% 9/1 | – | $1,113 萬 | 5.1% | – | – | – |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 100,000 | $1,033 萬 | 4.8% | −25,087−20.1% | 減碼 | 歷史 |
| KURAKura Oncology, Inc. | COM | 675,753 | $923.1 萬 | 4.3% | −252,503−27.2% | 減碼 | 歷史 |
| LNTHLantheus Holdings, Inc. | Stock | 130,000 | $914.3 萬 | 4.2% | −10,000−7.1% | 減碼 | 歷史 |
| NARIInari Medical, Inc. | Stock | 120,000 | $871.7 萬 | 4.0% | −102,173−46.0% | 減碼 | 歷史 |
| Nanostring Technologies Inc63009RAD1 | NOTE 2.625% 5/0 | – | $854.4 萬 | 3.9% | – | – | – |
| AZNAstraZeneca PLC | SPONSORED ADR | 150,000 | $822.6 萬 | 3.8% | +65,000+76.5% | 加碼 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 100,000 | $649.9 萬 | 3.0% | 00.0% | 不變 | 歷史 |
| VTYXVentyx Biosciences, Inc. | COM | 170,000 | $593.5 萬 | 2.7% | +170,000 | 新進 | 歷史 |
| PNTPOINT Biopharma Global Inc. | COM | 746,576 | $577.1 萬 | 2.7% | +720,998+2,818.8% | 加碼 | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 473,597 | $500.1 萬 | 2.3% | −19,681−4.0% | 減碼 | – |
| SWTXSpringWorks Therapeutics, Inc. | COM | 175,000 | $499.3 萬 | 2.3% | +175,000 | 新進 | 歷史 |
| CBAYCymaBay Therapeutics, Inc. | COM | 1,290,511 | $451.7 萬 | 2.1% | −81,733−6.0% | 減碼 | 歷史 |
| BridgeBio Pharma, Inc.10806XAB8 | NOTE 2.500% 3/1 | – | $449.1 萬 | 2.1% | – | – | – |
| BridgeBio Pharma, Inc.10806XAD4 | NOTE 2.250% 2/0 | – | $443.7 萬 | 2.0% | – | – | – |
| RCKTRocket Pharmaceuticals, Inc. | COM | 267,794 | $427.4 萬 | 2.0% | +17,328+6.9% | 加碼 | 歷史 |
| MORFMorphic Holding, Inc. | COM | 146,491 | $414.6 萬 | 1.9% | −69,232−32.1% | 減碼 | 歷史 |
| ACLXArcellx, Inc. | COMMON STOCK | 210,138 | $394.4 萬 | 1.8% | +135,138+180.2% | 加碼 | 歷史 |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 170,000 | $368.2 萬 | 1.7% | +100,000+142.9% | 加碼 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 400,043 | $361.6 萬 | 1.7% | +400,043 | 新進 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 350,000 | $357.7 萬 | 1.6% | +350,000 | 新進 | 歷史 |
| ARYEARYA Sciences Acquisition Corp V | CLASS A ORD SHS | 352,500 | $346.5 萬 | 1.6% | 00.0% | 不變 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 65,000 | $314.9 萬 | 1.5% | +50,000+333.3% | 加碼 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 154,087 | $229.9 萬 | 1.1% | +29,087+23.3% | 加碼 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 80,000 | $224.9 萬 | 1.0% | +40,000+100.0% | 加碼 | 歷史 |
| GSKGSK plc | ADR | 75,000 | $220.7 萬 | 1.0% | +75,000 | 新進 | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 136,434 | $214.7 萬 | 1.0% | +36,434+36.4% | 加碼 | 歷史 |
| VINCVincerx Pharma, Inc. | COM NEW | 1,492,771 | $206.0 萬 | 0.9% | +118,673+8.6% | 加碼 | 歷史 |
| RXDXPrometheus Biosciences, Inc. | COM | 25,000 | $147.5 萬 | 0.7% | +25,000 | 新進 | 歷史 |
| Intrexon Corp46122TAA0 | NOTE 3.500% 7/0 | – | $145.5 萬 | 0.7% | – | 新進 | – |
| KALVKalVista Pharmaceuticals, Inc. | COM | 96,318 | $139.8 萬 | 0.6% | +96,318 | 新進 | 歷史 |
| LIANYLianBio | SPONSORED ADS | 550,000 | $109.5 萬 | 0.5% | +100,000+22.2% | 加碼 | 歷史 |
| CNTXContext Therapeutics Inc. | COM | 883,654 | $98.1 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 242,517 | $97.5 萬 | 0.4% | +242,517 | 新進 | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 110,000 | $79.2 萬 | 0.4% | +110,000 | 新進 | 歷史 |
| NAUTNautilus Biotechnology, Inc. | COM | 372,476 | $79.0 萬 | 0.4% | −94,131−20.2% | 減碼 | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 250,000 | $68.0 萬 | 0.3% | +250,000 | 新進 | 歷史 |
| Immatics N.V.N44445117 | *W EXP 07/01/202 | 187,204 | $50.7 萬 | 0.2% | 00.0% | 不變 | – |
| RCORRenovacor, Inc. | COM | 199,490 | $50.3 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| TNGXTango Therapeutics, Inc. | COM | 81,982 | $29.7 萬 | 0.1% | +81,982 | 新進 | 歷史 |
| Vickers Vantage Corp IG9440B115 | *W EXP 09/15/202 | 100,000 | $1.70 萬 | <0.1% | +100,000 | 新進 | – |
| Renovacor, Inc.75989E114 | *W EXP 99/99/999 | 75,000 | $6,000 | <0.1% | 00.0% | 不變 | – |
| Medicus Sciences AcquisitionG5960S124 | *W EXP 02/12/202 | 33,333 | $3,000 | <0.1% | 00.0% | 不變 | – |
選擇權（16 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| SPYSPDR S&P 500 ETF Trust | ETF | $8,930 萬 | – |
| iShares Russell 2000 ETF464287655 | ETF | $1,154 萬 | – |
| SNYSanofi | SPONSORED ADR | $950.5 萬 | – |
| AZNAstraZeneca PLC | SPONSORED ADR | $548.4 萬 | – |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | $487.4 萬 | – |
| PENPenumbra Inc | COM | – | $474.0 萬 |
| GSKGSK plc | ADR | $323.7 萬 | – |
| GERNGeron Corp | COM | $152.1 萬 | $146.5 萬 |
| LNTHLantheus Holdings, Inc. | Stock | $211.0 萬 | – |
| FXEInvesco CurrencyShares Euro Trust | EURO SHS | $180.9 萬 | – |
| VRNAVerona Pharma plc | SPONSORED ADS | $168.7 萬 | – |
| MISTMilestone Pharmaceuticals Inc. | COM | – | $126.1 萬 |
| FXBInvesco CurrencyShares British Pound Sterling Trust | BRIT POUN STRL | $107.3 萬 | – |
| VERVVerve Therapeutics, Inc. | COM | – | $68.7 萬 |
| ISEEIVERIC bio, Inc. | COM | – | $53.8 萬 |
| KURAKura Oncology, Inc. | COM | $50.7 萬 | – |
2022 年第 2 季之後清倉（8 檔）
2022 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2022 年第 2 季股數 | 2022 年第 2 季市值 | 2022 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 75,000 | $598.2 萬 | 3.3% | 歷史 |
| KRTXKaruna Therapeutics, Inc. | COM | 45,000 | $569.3 萬 | 3.1% | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 321,200 | $449.4 萬 | 2.5% | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 401,268 | $99.5 萬 | 0.5% | 歷史 |
| SPRYARS Pharmaceuticals, Inc. | COM | 170,000 | $72.1 萬 | 0.4% | 歷史 |
| SNCEScience 37 Holdings, Inc. | COM | 279,775 | $56.2 萬 | 0.3% | 歷史 |
| CRISCuris Inc | COM NEW | 340,349 | $33.5 萬 | 0.2% | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 20,660 | $23.9 萬 | 0.1% | 歷史 |